Acute doses of d-amphetamine and bupropion increase cigarette smoking

Psychopharmacology

Volumn 157, Issue 3, 2001, Pages 243-253

  Cousins, Michael S ^a   Stamat, Heather M ^a   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amphetamine; Bupropion; Craving; Human; Smoking; Stimulant; Withdrawal

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; PLACEBO;

ABSTINENCE; ADULT; ARTICLE; BEHAVIOR; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EUPHORIA; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; WITHDRAWAL SYNDROME;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; EUPHORIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SEX CHARACTERISTICS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0034808268     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100802     Document Type: Article

References (68)

1. An inventory for measuring depression
2. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers
3. Effects of caffeine on cigarette smoking and subjective response
4. The discriminative stimulus and subjective effects of d-amphetamine in humans
5. Experimental model of smoking re-exposure: Effects on relapse
6. Tobacco smoking, genes, and dopamine
7. Craving, individual differences, and stages of change: Evaluation of smokers in a nicotine dependence program
8. Priming effects with drugs and other reinforcers
9. Testing the abuse liability of anxiolytic and hypnotic drugs in humans
10. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam
11. Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers
12. A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients
13. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion HCl - A new atypical antidepressant agent
14. Non-nicotine pharmacotherapy for smoking cessation
15. Efficacy of bupropion for smoking cessation in non-depressed smokers
16. Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects
17. Assessment of abuse liability of stimulant drugs in humans: A methodological survey
18. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine
19. Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers
20. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism
21. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire
22. Cigarette smoking and subjective responses: Effects of d-amphetamine
23. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine
24. Bupropion: A review of its use in the management of smoking cessation
25. Signs and symptoms of tobacco withdrawal
26. Errors in using tobacco withdrawal scale
27. A comparison of sustained-release bupropion and placebo for smoking cessation
28. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms
29. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
30. The effects of repeated amphetamine exposure on multiple measures of human behavior
31. Naltrexone alteration of acute smoking response in nicotine-dependent subjects
32. How does physician advice influence patient behavior? Evidence for a priming effect
33. Transdermal nicotine effects on attention
34. The effect of d-amphetamine and ephedrine on smoking attitude and behavior
35. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man
36. Hormonal and subjective effects of smoking the first five cigarettes of the day: A comparison in males and females
37. Practical therapeutics: Benzedrine sulfate in the treatment of nicotinism
38. What predicts relapse? Prospective testing of antecedent models
39. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis
40. Psychopharmacology of bupropion in normal volunteers
41. A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects
42. Chronic and acute tolerance to subjective effects of nicotine
43. Common neural substrates for the addictive properties of nicotine and cocaine
44. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
45. Functional correlates of nicotine administration: Similarity with drugs of abuse
46. The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses
47. Cocaine use can increase cigarette smoking: Evidence from laboratory and naturalistic settings
48. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking
49. Mecamylamine increases nicotine preference and attenuates nicotine discrimination
50. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans
51. A shortened version of the profile of mood states
52. The effects of d-amphetamine, meprobamate, and lobeline on the cigarette smoking behavior of normal human subjects
53. The Michigan alcoholism screening test
54. Relapse following smoking cessation: A situational analysis
55. The effect of bupropion on nicotine craving and withdrawal
56. Is dopamine important in nicotine dependence?
57. Nicotine-induced place preferences following prior nicotine exposure in rats
58. Bupropion is a nicotinic antagonist
59. The scientific case that nicotine is addictive
60. The development and initial validation of a questionnaire on smoking urges
61. Activity of dopamine-containing substantia nigra neurons in freely moving cats
62. Subjective and behavioral effects of repeated d-amphetamine in humans
63. Subjective and behavioural evaluation of cigarette cravings
64. Comparative efficacy and safety of bupropion and placebo in the treatment of depression